These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25421045)

  • 41. A Literature Review of Genetic Markers Conferring Impaired Response to Cardiovascular Drugs.
    Shukla H; Mason JL; Sabyah A
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):259-269. PubMed ID: 29536347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.
    Friede K; Li J; Voora D
    Clin Chem; 2017 Jan; 63(1):177-185. PubMed ID: 27864383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nursing; 2011; 41 Suppl():1-7. PubMed ID: 21343749
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
    Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Practical guidelines for genetic testing in cardiovascular diseases].
    Reinhard W; Trenkwalder T; Schunkert H
    Herz; 2017 Aug; 42(5):485-491. PubMed ID: 28484805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of cardiac genetic testing.
    Ingles J; Semsarian C
    Trends Cardiovasc Med; 2014 Aug; 24(6):217-24. PubMed ID: 25066489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular biological studies in clinical laboratory diagnosis: potentialities and problems (a lecture)].
    Men'shikov VV
    Klin Lab Diagn; 2006 Mar; (3):23-32. PubMed ID: 16749487
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiovascular disease strategies--directions after the human genome.
    Barone FC
    Curr Opin Investig Drugs; 2006 Sep; 7(9):789-91. PubMed ID: 17002255
    [No Abstract]   [Full Text] [Related]  

  • 49. Personalized cardiovascular medicine: status in 2012.
    Dandona S; Roberts R
    Can J Cardiol; 2012; 28(6):693-9. PubMed ID: 23036280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic Testing for Inherited Cardiovascular Disease: Implications of the AHA Scientific Statement for Cardiologists.
    Gray B; Semsarian C
    Heart Lung Circ; 2020 Nov; 29(11):1581-1584. PubMed ID: 33008731
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cardiovascular pharmacology].
    Ravens U; Erdmann E
    Dtsch Med Wochenschr; 2004 Apr; 129(15):799. PubMed ID: 15054684
    [No Abstract]   [Full Text] [Related]  

  • 52. Personalised medicine: not just in our genes.
    Kitsios GD; Kent DM
    BMJ; 2012 Apr; 344():e2161. PubMed ID: 22491484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene tests for some, not all. Genetic testing helps some people glimpse their cardiovascular future.
    Harv Heart Lett; 2008 Jan; 18(5):1-2. PubMed ID: 18293528
    [No Abstract]   [Full Text] [Related]  

  • 54. Prasugrel, Māori, and personalised medicine in New Zealand.
    Gladding P; White H; Webster M
    N Z Med J; 2010 Mar; 123(1310):86-90. PubMed ID: 20360782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.
    Kaufman AL; Spitz J; Jacobs M; Sorrentino M; Yuen S; Danahey K; Saner D; Klein TE; Altman RB; Ratain MJ; O'Donnell PH
    Mayo Clin Proc; 2015 Jun; 90(6):716-29. PubMed ID: 26046407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular pipeline decline quantified.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681785
    [No Abstract]   [Full Text] [Related]  

  • 57. Training in cardiovascular genetics.
    Beauséjour Ladouceur V
    J Am Coll Cardiol; 2015 Mar; 65(8):856-858. PubMed ID: 25720629
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.
    Austin SE; Hegele RA
    Can J Cardiol; 2011; 27(6):682-4. PubMed ID: 21652171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Special report: cardiovascular pharmacogenomics.
    Technol Eval Cent Assess Program Exec Summ; 2007 Nov; 22(7):1-4. PubMed ID: 18080408
    [No Abstract]   [Full Text] [Related]  

  • 60. [Genetic testing].
    Delpech M
    Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1030-2. PubMed ID: 14694777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.